This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

16 Feb 2011

Catalent Signs Deal with Pantec for Lyopan Technology

Catalent has expanded its oral dose capabilities by signing an agreement with Pantec for the Swiss development company’s Lyopan fast-dissolve technology.

Catalent Pharma Solutions has signed a license agreement with Pantec AG for the exclusive worldwide development rights to the Lyopan fast-dissolve technology which requires significantly less water than existing technology.


The Lyopan technology is able to reduce energy consumption, sublimation and drying time. The technology also offers the potential for improved tas

Related News